February 2024
1. MAUGHAN BC, Jarman AF, Redmond A, Geersing GJ, et al
   Pulmonary embolism.
   BMJ. 2024;384:e071662.
   

   >> Share

   
   October 2023
2. BOYCE S, McFarlane E, Harrison S, McCormack T, et al
   Diagnosis of venous thromboembolic diseases in people with covid-19: summary of updated NICE guidance.
   BMJ. 2023;383:p2204.
   

   >> Share

   
   September 2023
3. SCHMIDT M
   NSAIDs, hormonal contraception, and venous thromboembolism.
   BMJ. 2023;382:p1990.
   

   >> Share

   
   
4. MEAIDI A, Mascolo A, Sessa M, Toft-Petersen AP, et al
   Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
   BMJ. 2023;382:e074450.
   

   >> Share

   
   June 2023
5. GUNTUPALLI SR, Spinosa D, Wethington S, Eskander R, et al
   Prevention of venous thromboembolism in patients with cancer.
   BMJ. 2023;381:e072715.
   

   >> Share

   
   November 2022
6. AGENO W, Bertu L, Bucherini E, Camporese G, et al
   Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.
   BMJ. 2022;379:e072623.
   

   >> Share

   
   October 2022
7. LI X, Burn E, Duarte-Salles T, Yin C, et al
   Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.
   BMJ. 2022;379:e071594.
   

   >> Share

   
   April 2022
8. HO FK, Pell JP
   Thromboembolism and bleeding after covid-19.
   BMJ. 2022;377:o817.
   

   >> Share

   
   
9. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Jerndal H, et al
   Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.
   BMJ. 2022;377:e069590.
   

   >> Share

   
   March 2022
10. MARCUCCI M, Etxeandia-Ikobaltzeta I, Yang S, Germini F, et al
    Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
    BMJ. 2022;376:e066785.
    

    >> Share

    
    August 2021
11. HIPPISLEY-COX J, Patone M, Mei XW, Saatci D, et al
    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    BMJ. 2021;374:n1931.
    

    >> Share

    
    June 2021
12. BLANK M, Collas O, Hirji H
    A young man with shortness of breath.
    BMJ. 2021;373:n1313.
    

    >> Share

    
    
13. KOVACS MJ, Wells PS, Anderson DR, Lazo-Langner A, et al
    Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
    BMJ. 2021;373:n1205.
    

    >> Share

    
    May 2021
14. HORNER D, Goodacre S, Davis S, Burton N, et al
    Which is the best model to assess risk for venous thromboembolism in hospitalised patients?
    BMJ. 2021;373:n1106.
    

    >> Share

    
    
15. PERERA R, Fletcher J
    Thromboembolism and the Oxford-AstraZeneca vaccine.
    BMJ. 2021;373:n1159.
    

    >> Share

    
    
16. POTTEGARD A, Lund LC, Karlstad O, Dahl J, et al
    Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
    BMJ. 2021;373:n1114.
    

    >> Share

    
    January 2021
17. SALMAN D, Vishnubala D, Le Feuvre P, Beaney T, et al
    Returning to physical activity after covid-19.
    BMJ. 2021;372:m4721.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share